GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. Logo

GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş.

Specialty pharmaceutical firm for rare diseases and unmet medical needs.

GENIL | IS

Overview

Corporate Details

ISIN(s):
TREGENL00016 (+1 more)
LEI:
789000A4NW6W4D8Z4H25
Country:
Türkiye
Address:
MUSTAFA KEMAL MAH. 2119. SOK. NO;3 D:2-3 ÇANKAYA/ANKARA, 06520 ANKARA

Description

GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. is a specialty pharmaceutical company established in 1998 that provides solutions for rare diseases and unmet medical needs. The company operates a GMP-certified manufacturing facility and an R&D center to develop, produce, and supply a wide range of products for international markets. Its business model combines strategic partnerships with global firms and in-house innovation to address complex health challenges, leveraging over 25 years of experience in its specialized therapeutic areas.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2024-06-07 14:47
2024 Yılı İlk Çeyrek Yatırımcı Sunumu
Turkish PDF 4.2 MB
2024-06-07 14:47
2024 Yılı İlk Çeyrek Yatırımcı Sunumu
Turkish HTML 17.0 KB
2024-06-04 17:06
2023 Yılı Dönem Karından ilk taksitin dağıtılması
Turkish PDF 106.2 KB
2024-06-04 17:06
2023 Yılı Dönem Karından ilk taksitin dağıtılması
Turkish HTML 38.9 KB
2024-06-03 17:16
Financial Report
Turkish PDF 1020.7 KB
2024-06-03 17:16
Financial Report
English HTML 2.5 MB
2024-06-03 17:16
01.01.2024 - 31.03.2024 Interim Period Activity Report
Turkish PDF 584.3 KB
2024-06-03 17:16
01.01.2024 - 31.03.2024 Interim Period Activity Report
Turkish PDF 691.9 KB
2024-06-03 17:16
01.01.2024 - 31.03.2024 Interim Period Activity Report
Turkish HTML 11.1 KB
2024-06-03 17:15
01.01.2024 - 31.03.2024 Sorumluluk Beyanı
Turkish HTML 23.2 KB
2024-05-23 17:10
Şirketimizin Halka Arz'dan Elde Ettiği Fonun Tamamının Kullanımı
Turkish PDF 204.1 KB
2024-05-23 17:10
Şirketimizin Halka Arz'dan Elde Ettiği Fonun Tamamının Kullanımı
Turkish HTML 15.5 KB
2024-05-21 15:22
Company General Info Form
Turkish HTML 12.4 KB
2024-05-20 17:10
2024 Birinci Dönem Geçici Vergi Beyannamesi Ekinde Sunulan Gelir Tablosu
Turkish PDF 192.5 KB
2024-05-20 17:10
2024 Birinci Dönem Geçici Vergi Beyannamesi Ekinde Sunulan Gelir Tablosu
Turkish HTML 26.5 KB

Automate Your Workflow. Get a real-time feed of all GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Crinetics Pharmaceuticals, Inc. Logo
Develops oral therapeutics for endocrine diseases and endocrine-related tumors.
United States of America
CRNX
Develops drug delivery technology for localized chemotherapy in solid tumors.
Virgin Islands (British)
CRTX
CRISPR Therapeutics AG Logo
A gene-editing company developing gene-based medicines for serious diseases.
United States of America
CRSP
Crossject Logo
Develops emergency medications delivered via a needle-free auto-injector platform.
France
ALCJ
CSL Ltd. Logo
Global biotechnology company developing biotherapies, vaccines, and specialty medicines.
Australia
CSL
CS Medica A/S Logo
Develops and manufactures OTC medical devices and cosmetics containing cannabidiol.
Denmark
CSMED
CTC BIO, INC. Logo
Develops and manufactures human and animal health products using microbial fermentation.
South Korea
060590
Cue Biopharma, Inc. Logo
Develops biologics to selectively modulate the immune system for cancer and autoimmune diseases.
United States of America
CUE
Cullinan Therapeutics, Inc. Logo
A clinical-stage biopharmaceutical company developing therapies for cancer and autoimmune diseases.
United States of America
CGEM
CUMBERLAND PHARMACEUTICALS INC Logo
Acquires, develops, and commercializes branded drugs for hospital and acute care.
United States of America
CPIX

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.